Follow
Sivaraj Anbarasu
Sivaraj Anbarasu
Director, Haryni Healthtech
No verified email
Title
Cited by
Cited by
Year
Commercial yeast extracts mediated green synthesis of silver chloride nanoparticles and their anti-mycobacterial activity
A Sivaraj, V Kumar, R Sunder, K Parthasarathy, G Kasivelu
Journal of Cluster Science 31, 287-291, 2020
562020
Discovery of a novel mycobacterial F‐ATP synthase inhibitor and its potency in combination with diarylquinolines
A Hotra, P Ragunathan, PS Ng, P Seankongsuk, A Harikishore, ...
Angewandte Chemie International Edition 59 (32), 13295-13304, 2020
392020
Unveiling the anticancer and antimycobacterial potentials of bioengineered gold nanoparticles
K Govindaraju, R Vasantharaja, KSU Suganya, S Anbarasu, K Revathy, ...
Process Biochemistry 96, 213-219, 2020
302020
Seaweed (Turbinaria ornata)-assisted green synthesis of magnesium hydroxide [Mg (OH) 2] nanomaterials and their anti-mycobacterial activity
K Govindaraju, KV Anand, S Anbarasu, J Theerthagiri, S Revathy, ...
Materials Chemistry and Physics 239, 122007, 2020
262020
Application of fuzzy regression analysis in predicting the performance of the anaerobic reactor co-digesting spent tea waste with cow manure
N Khayum, A Rout, B Deepak, S Anbarasu, S Murugan
Waste and Biomass Valorization 11, 5665-5678, 2020
222020
Silver nanoparticles synthesized from the seaweed Sargassum polycystum and screening for their biological potential
R Thiurunavukkarau, S Shanmugam, K Subramanian, P Pandi, ...
Scientific Reports 12 (1), 14757, 2022
172022
Green synthesis of gold nanoparticles using extracellular metabolites of fish gut microbes and their antimicrobial properties
T Rajasekar, K Karthika, G Muralitharan, A Maryshamya, S Sabarika, ...
Brazilian journal of microbiology 51, 957-967, 2020
172020
Potential applications of lactic acid bacteria and bacteriocins in anti-mycobacterial therapy
A Sivaraj, R Sundar, R Manikkam, K Parthasarathy, U Rani, V Kumar
Asian pacific journal of tropical medicine 11 (8), 453-459, 2018
162018
Inhibitory activity of Euphorbia hirta (Tawa-tawa) extracts against Mycobacterium tuberculosis and other non mycobacterial pathogens
T Rajasekar, S Anbarasu, R Manikkam, J Joseph, V Kumar
Der Pharma Chemica 7 (8), 213-216, 2015
132015
3-Substituted-2-oxindole derivatives: Design, synthesis and their anti-tuberculosis and radical scavenging dual-action studies
M Hublikar, V Kadu, D Raut, S Shirame, S Anbarasu, MK Al-Muhanna, ...
Journal of Molecular Structure 1261, 132903, 2022
82022
Quality indicators in a mycobacteriology laboratory supporting clinical trials for pulmonary tuberculosis
N Selvakumar, K Silambuchelvi, MG Sekar, AS Sunder, S Anbarasu, ...
International journal of mycobacteriology 1 (4), 185-189, 2012
82012
Biogenic production of Gold nanoparticles using Lactic acid bacteria and their Anti-mycobacterial activity
A Sivaraj, V Kumar, R Kalyanasundaram, G Kasivelu
Research Journal of Pharmacy and Technology 13 (9), 4391-4394, 2020
72020
Phytochemical, ethnomedicinal and pharmacological potentials of seabuckthorn—a mini review
S Anbarasu, M Radhakrishnan, A Suresh, J Joseph
Int J Pharma Bio Sci 6 (3), 263-272, 2015
72015
A Novel Finding: 2,4-Di-tert-butylphenol from Streptomyces bacillaris ANS2 Effective Against Mycobacterium tuberculosis and Cancer Cell Lines
M Kaari, J Joseph, R Manikkam, R Kalyanasundaram, A Sivaraj, ...
Applied Biochemistry and Biotechnology 195 (11), 6572-6585, 2023
52023
Evaluating the anti-mycobacterial activity of Nigella sativa seed extracts
S Anbarasu, R Sundar, K Manigundan, T Rajasekar, M Shamya, J Joseph
Der Pharm Lett 10 (7), 1-9, 2018
42018
Recovery of Mycobacterium tuberculosis from Löwenstein-Jensen media contaminated with other organisms
P Nagarajan, S Anbarasu, V Kumar, N Selvakumar
The International journal of tuberculosis and lung disease 16 (2), 230-231, 2012
42012
Identification of new efflux pump proteins from multidrug resistant Mycobacterium tuberculosis and screening for peptide based efflux pump inhibitors
K Parthasarathy, A Sivaraj, R Sundar
International Journal of Infectious Diseases 45, 404-405, 2016
32016
Isolation of colicinogenic E. coli, optimization of colicin production and transformation of Col plasmid
A Suresh, M Radhakrishnan, G Suresh, N Prasannabalaji, S Anbarasu, ...
Journal of Applied Pharmaceutical Science 4 (7), 047-049, 2014
32014
Activity and toxicity assessment of partially purified bacteriocin from lactic acid bacteria against Mycobacterium kansasii
R Kalyanasundaram, M Radhakrishnan, S Anbarasu
Annals of the Romanian Society for Cell Biology, 6715-6721, 2021
22021
Isolation, characterization of lactic acid bacteria from cow and buffalo milk and evaluation for antibacterial and antimycobacterial activity in vitro
K Revathy, M Radhakrishnan, A Sivaraj
Asian Journal of Microbiology Biotechnology and Environmental Sciences 21 (4 …, 2019
22019
The system can't perform the operation now. Try again later.
Articles 1–20